What is the typical treatment plan for a patient experiencing a Chronic Obstructive Pulmonary Disease (COPD) exacerbation?

COPD Exacerbation SOAP Note

Subjective

Document the acute worsening of respiratory symptoms over the past 14 days or less, focusing on the cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence. 1

• Dyspnea severity: Quantify breathlessness at rest versus with exertion, ability to speak in full sentences, and any orthopnea 2
• Sputum characteristics: Color (green/yellow indicates purulence), volume increase, and consistency 2
• Cough frequency and productivity 1
• Baseline COPD severity: Previous FEV1, home oxygen use, frequency of prior exacerbations (≥2 per year defines frequent exacerbator) 1
• Medication adherence: Current bronchodilator use, inhaler technique, recent antibiotic or steroid courses 1
• Smoking status: Current use and pack-year history 1
• Comorbidities: Heart failure, diabetes, renal/liver disease, pneumonia symptoms 2
• Red flag symptoms: Confusion, altered mental status, chest pain, hemoptysis 2, 3

Objective

Vital signs and physical examination findings determine severity and disposition (outpatient versus hospital versus ICU). 2

Critical Assessment Parameters:

• Respiratory rate: Tachypnea >24 breaths/min indicates severity 3
• Oxygen saturation: SpO2 <90% on room air requires supplemental oxygen 2
• Heart rate and blood pressure: Hemodynamic instability mandates ICU admission 2
• Mental status: Confusion or decreased alertness indicates severe exacerbation 1, 2
• Physical signs: Cyanosis, use of accessory muscles, peripheral edema, elevated jugular venous pressure 2, 3
• Lung examination: Wheezing, prolonged expiration, decreased breath sounds 3

Laboratory and Diagnostic Studies:

• Arterial blood gas (ABG): Mandatory for severe exacerbations to assess PaO2, PaCO2, and pH; respiratory acidosis (pH <7.26) indicates need for NIV 1, 2, 3
• Chest radiograph: Rule out pneumonia, pneumothorax, pleural effusion 3
• Complete blood count, electrolytes, renal function: Assess for infection and metabolic derangements 3
• ECG: Evaluate for cardiac arrhythmia or ischemia 3
• Peak expiratory flow or FEV1: Establish baseline and monitor response 1, 3

Assessment

COPD exacerbation severity classification determines treatment setting and intensity.

Mild Exacerbation (Outpatient Management):

• Increased symptoms manageable with increased bronchodilator use 1
• No respiratory distress at rest 2
• SpO2 ≥90% on room air 2

Moderate-to-Severe Exacerbation (Hospitalization Indicated):

• Marked increase in dyspnea severity 2
• New physical signs (cyanosis, peripheral edema) 2
• Failure to respond to initial outpatient treatment 2
• Significant comorbidities present 2

Life-Threatening Exacerbation (ICU Admission Required):

• Impending or actual respiratory failure 2
• Respiratory acidosis (pH <7.26) despite medical management 2, 3
• Hemodynamic instability 2
• Altered mental status or confusion 2

Plan

Outpatient Management (Mild Exacerbations)

Bronchodilator Therapy:

Increase short-acting β2-agonists (albuterol/salbutamol) to 2-4 puffs every 4 hours via MDI with spacer, or 2.5-5 mg via nebulizer every 4-6 hours. 1, 2

• Add ipratropium bromide 2-4 puffs (18 mcg/puff) every 4 hours or 0.5 mg via nebulizer for additional bronchodilation 2, 4
• Consider adding long-acting bronchodilator if not already prescribed 2

Systemic Corticosteroids:

Prescribe prednisone 40 mg orally daily for 5 days. 1, 2

• This 5-day course is as effective as longer durations and minimizes adverse effects 1, 2
• Oral administration is equally effective as intravenous 1

Antibiotic Therapy:

Initiate antibiotics if sputum is purulent (green/yellow) or increased in volume. 2

• First-line options: Amoxicillin 500 mg three times daily, doxycycline 100 mg twice daily, or azithromycin 500 mg day 1 then 250 mg daily for 5-7 days total 2
• Consider local resistance patterns and recent antibiotic exposure 2, 4
• Common pathogens: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis 2

Follow-up:

• Reassess in 48-72 hours to evaluate response 2
• If no improvement or worsening, consider hospitalization 2

---

Hospital Management (Moderate-to-Severe Exacerbations)

Oxygen Therapy:

Target SpO2 of 88-92% to prevent worsening hypercapnia while ensuring adequate tissue oxygenation. 2, 3

• Start with nasal cannula 1-2 L/min or Venturi mask 24-28% 3
• Repeat ABG within 60 minutes of initiating oxygen to assess for CO2 retention 3
• Prevention of tissue hypoxia takes precedence over CO2 retention concerns 2

Bronchodilator Therapy:

Administer albuterol 2.5-5 mg via nebulizer every 1-4 hours (or continuous nebulization at 10-20 mg/hour for severe cases). 1, 3

• Add ipratropium bromide 0.5 mg via nebulizer every 4-6 hours 1, 2, 3
• Use compressed air (not oxygen) to drive nebulizers if patient has hypercapnia 3
• MDI with spacer is equally effective as nebulizer but nebulizer may be easier for severely ill patients 1

Systemic Corticosteroids:

Administer prednisone 40 mg orally daily or methylprednisolone 40 mg IV daily for 5-7 days. 1, 2

• Oral and IV routes are equally effective 1, 2
• Do not exceed 7-14 days of treatment to minimize adverse effects 1, 2, 3
• Corticosteroids improve FEV1, oxygenation, shorten recovery time, and reduce hospitalization length 1

Antibiotic Therapy:

Prescribe antibiotics for 5-7 days if sputum is purulent or patient has severe exacerbation. 1, 2

• First-line: Amoxicillin or doxycycline unless recently used with poor response 3
• For severe exacerbations: Broad-spectrum cephalosporins or respiratory fluoroquinolones (levofloxacin 750 mg daily) 3
• Antibiotics reduce treatment failure, early relapse, and hospitalization duration 1

Additional Interventions:

• Diuretics: Only if peripheral edema and elevated jugular venous pressure present 2, 3
• Thromboembolism prophylaxis: Subcutaneous heparin 5,000 units twice daily 3
• Avoid chest physiotherapy: Not recommended in acute COPD exacerbations 2, 3

Methylxanthines (Second-Line):

Consider aminophylline 0.5 mg/kg/hour IV continuous infusion only if inadequate response to first-line bronchodilators. 3

• Monitor serum levels daily (target 5-15 μg/mL) 1, 3
• Not routinely recommended due to increased side effects 1

---

ICU Management (Life-Threatening Exacerbations)

Non-Invasive Ventilation (NIV):

Initiate NIV immediately if respiratory acidosis persists (pH <7.26) despite maximal medical therapy. 1, 2, 3

• NIV reduces intubation rates, mortality, and hospital length of stay 1, 3
• Contraindications: Confusion, inability to protect airway, large volume secretions, hemodynamic instability 3

Invasive Mechanical Ventilation:

Intubate if NIV fails, patient cannot tolerate NIV, or severe respiratory failure with altered mental status. 2

• Ventilator settings: Low tidal volume (6-8 mL/kg), prolonged expiratory time, low respiratory rate to minimize auto-PEEP 5
• Monitor for auto-PEEP and adjust ventilator settings accordingly 5
• Extubate to NIV when ready to improve outcomes 5

---

Discharge Planning and Follow-up

Ensure patient meets discharge criteria: stable on oral/inhaled medications, SpO2 ≥90% on room air or baseline oxygen, able to ambulate, and adequate home support. 3

Discharge Medications:

• Continue short-acting bronchodilators as needed 2
• Optimize long-acting bronchodilators (LAMA/LABA combination for frequent exacerbators) 6
• Verify proper inhaler technique before discharge 3
• Provide spacer devices for MDIs 1

Pulmonary Rehabilitation:

Refer to pulmonary rehabilitation within 3 weeks of hospital discharge. 2, 3

• Improves exercise capacity, quality of life, and reduces future exacerbations 2
• Do not initiate during acute hospitalization 2

Follow-up:

• Schedule outpatient visit within 4-6 weeks to reassess symptoms, lung function, and medication regimen 1, 3
• Review smoking cessation strategies at every visit 1
• Ensure pneumococcal and annual influenza vaccination 7

---

Common Pitfalls to Avoid

• Uncontrolled high-flow oxygen: Worsens hypercapnia; always target SpO2 88-92% 3
• Prolonged corticosteroid courses: No benefit beyond 5-7 days and increases adverse effects 1, 2
• Routine chest physiotherapy: Not beneficial in acute exacerbations 2, 3
• Overuse of methylxanthines: Reserve for refractory cases due to side effect profile 1, 3
• Inadequate inhaler education: Verify technique before discharge to prevent readmission 3